The devastating reality of a motor neurone disease (MND) diagnosis hit home for one Australian woman when her husband, Andrew, received the life-limiting prognosis at just 51. The neurologist’s words in October 2024, delivered with stark clarity, were a brutal blow. MND, a condition affecting the brain and spinal cord, leads to progressive muscle weakness, ultimately rendering movement, speech, swallowing, and breathing impossible.
Initially, disbelief clouded the diagnosis. Andrew was fit and healthy, and previous assurances had suggested MND was unlikely. The doctor’s advice to avoid researching life expectancy was, predictably, the first thing they disregarded. The grim reality of the average prognosis – a mere two to three years with no known cure – was a hard pill to swallow. Tragically, Andrew’s fight against the disease was short-lived. He passed away on 29th November 2025, just 13 months after his diagnosis.
The profound grief of this loss was compounded by the news of actor Eric Dane’s passing from ALS, a form of MND, only 10 months after his diagnosis. The author, who understands the depth of this pain intimately, noted the shared age of their children with Dane’s and acknowledged the “absolute hell” such families endure.
Finding Strength in Shared Experience and Legacy
During their darkest period, the author found solace in the unwavering support of family and friends, particularly those who had navigated similar trials. The concept of Andrew’s legacy also provided a crucial anchor. This sentiment appears to be shared by Eric Dane, whose pre-death campaigning is believed to have significantly aided people living with MND in accessing necessary treatments. The author expressed profound gratitude for Dane’s willingness to leverage his public platform for awareness.
For Andrew, however, the swift progression of the disease meant that emerging treatments arrived too late. While a medicine was in development, MND is a relentless opponent where time is of the essence. The author’s fervent hope is that future patients will be afforded more time. Andrew’s physical decline was severe; his muscles weakened to the point where he could no longer effectively exhale, leading to respiratory failure, the ultimate cause of his death.
A Life Interrupted: From Love to Loss
The author’s own life has been marked by significant adversity, including fleeing the Bosnian war as a child. Yet, she states, nothing could have prepared her for the profound impact of Andrew’s MND diagnosis. Their journey together began online in 2006, with an instant connection forged on their first date in London’s Hyde Park. Their shared desire for marriage and children quickly led to a wedding within 18 months. They built a beautiful life together, renovating a Georgian home in Hampshire and raising their two children amidst a nurturing environment filled with walks, music, and art.
The first signs of trouble emerged in July 2024, when Andrew experienced muscle twitching in his limbs, which rapidly escalated to full-body spasms within weeks. While initially concerned, they didn’t immediately jump to the worst-case scenario, though MND remained a possibility. Facing lengthy waiting lists for an NHS neurologist, Andrew opted for a private consultation. This initial assessment suggested MND was unlikely, as he showed no immediate signs of Bulbar Palsy, a subtype affecting the tongue. However, Andrew was experiencing fatigue and mobility issues, including significant ankle weakness that hindered his ability to walk for extended periods.
The definitive diagnosis came in October 2024, during his NHS appointment. The reality was stark: Andrew had MND, and he was going to die. Despite efforts to maintain a positive outlook, the challenges mounted almost immediately.
The Relentless Progression of MND
By July 2025, Andrew’s condition had deteriorated significantly. He required 24/7 use of a breathing machine and was almost entirely reliant on tube feeding. Paralysis had taken hold, leaving him with only 20% functionality in one hand. This rapid decline mirrored the experiences of many MND patients, a pace they were ill-equipped to handle, despite medical warnings.
The heart-wrenching task of informing their two children was postponed for as long as possible. However, Andrew’s inability to even go for a walk made further prevarication impossible. Excuses like “Daddy has a lot of work” could no longer suffice. The moment of truth was undoubtedly the hardest they had ever faced.
Sitting on the sofa, Andrew gently explained to their children how his weakening ankle was part of a larger, serious problem. Tears flowed freely. Their daughter’s poignant question, “But what would be the point of life without you?” captured the profound impact of Andrew’s illness. Their son, while upset, displayed a practical concern, asking about the effect on his father’s salary, a question met with a mixture of humour and compassionate explanation.
Understanding Motor Neurone Disease
Motor neurone disease (MND) is a rare neurological condition impacting the brain and nerves. While most commonly affecting individuals in their 60s and 70s, it can manifest at any adult age. The disease arises from the malfunction and eventual death of motor neurones, the nerve cells responsible for transmitting signals from the brain to muscles. This progressive degeneration leads to increasing difficulties with movement, swallowing, and breathing.
Currently, there is no cure for MND, and it invariably shortens life expectancy. However, treatments such as physiotherapy and riluzole, a medication that can modestly slow progression, can help some individuals live with the condition for extended periods. While largely not hereditary, a family history of MND can slightly increase an individual’s risk.
The NHS outlines several early symptoms:
- Leg and Ankle Weakness: This can manifest as tripping or increased difficulty with stairs.
- Speech and Swallowing Difficulties: Slurred speech may progress to problems swallowing certain foods.
- Weak Grip: Dropping objects or struggling with tasks like opening jars or fastening buttons can be indicative.
- Muscle Cramps and Twitches: Involuntary muscle spasms are common.
- Unexplained Weight Loss: Muscles in the limbs may appear thinner over time.
- Emotional Lability: Difficulty controlling crying or laughing in inappropriate situations.
The NHS strongly advises consulting a GP if these symptoms arise. They emphasize that while MND is unlikely, early and accurate diagnosis is crucial for accessing timely care and support. For further information and assistance, the MND Association is a valuable resource.
Financial and Emotional Strain
Andrew’s illness was not just a health crisis; it was a profound life disruption, impacting every facet of their existence, including their finances. As an NHS consultant psychiatrist, Andrew was a consistent breadwinner, and his income was vital. His diagnosis necessitated immediate retirement rather than sick leave, a decision he was reluctant to make due to financial concerns. The author subsequently left her job as a guitar teacher to become his full-time carer.
Adding to their distress, Andrew’s life insurance initially refused to pay out, citing a baffling claim that he could recover from an incurable disease. Thankfully, they eventually relented, providing much-needed financial relief during this incredibly challenging and expensive period.
With Andrew unable to work and the author consumed by his care and childcare responsibilities, the family faced significant financial strain, struggling to meet mortgage payments and fearing the necessity of downsizing their home.
The Urgent Need for Research and Treatment
While local hospices offered invaluable palliative care and an MND charity provided a grant for a family holiday, the author highlights a critical gap: “there’s not enough being done to find a treatment or cure.” This lack of progress, she argues, is unacceptable for MND when compared to other diseases, especially given the devastating impact on families.
The path forward, she believes, lies in precision medicine and RNA therapy, which target genetic information to treat diseases by regulating protein expression and correcting genetic mutations. The rapid development of such therapies in the US within six months offers a glimmer of hope.
Despite Andrew’s rapid decline, the author and a UK-based team collaborated with a US biotech company to develop a precision medication aimed at targeting protein imbalances. This initiative represents a potential pathway towards a more effective and accessible treatment for MND sufferers.
Sadly, this groundbreaking work came too late for Andrew. He passed away just two months before the medication was completed. By the time the author became aware of the company in August 2025, the window of opportunity had closed.
With a short prognosis, only around 5,000 people are living with MND in the UK at any given time. These individuals, the author contends, may feel invisible, vulnerable, and abandoned.
A Plea for a Cure
The family is managing, with the author back at work and the children navigating their grief. They often reminisce about happier times, dreaming of a past where a cure for Andrew was a tangible possibility.
The author issues a passionate plea to break the silence surrounding MND and to accelerate the search for a cure. Her ultimate goal is to prevent other families, including Eric Dane’s, from enduring the same profound suffering her own family has experienced.
